Fourth Alzheimer’s Drug Approved: “Alzheimer’s sufferers are about to get a fourth
medication option to help slow the worsening of the devastating
brain disease.

The Food and Drug Administration approved
Reminyl, a drug derived from daffodil bulbs, late Wednesday.” The generic name of Reminyl is galantamine. It works via the same mechanism of existing Alzheimer’s drugs — it’s an acetylcholinesterase inhibitor. Early animnal research indicated that it might have other neuroprotective properties as well and, thus, be superior to existing medications for Alzheimer’s dementia. But in preapproval testing, the drug’s manufacturer Janssen tested it only agsinst placebo, nto against other Alzheimer’s drugs.